Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

Development of CAR-T cell

based on a newly identified tumor antigen

MJ Cellbio – Beyond New Horizon

. . .

MJCELLBIO

MJCellBio focuses on development of CAR-T cell targeting the new tumor antigen that has not been attempted before clinically. In addition, MJCellBio is working on development of ‘Universal (allogeneic) CAR-T cell’ overcoming the disadvantages of ‘autologous CAR-T cell’.

CAR-T Treatment

* LV: Lentivirus gene delivery system

CAR-T Cell Mediated Cytotoxicity

Business plan for CAR-T cell therapy product

LATEST NEWS

공동연구 계약 체결식(20.1.13)

엠제이셀 바이오(대표이사 이왕준)는 건국대학교 산학협력단( 연구책임자 조쌍구)과 유도만능줄기세포 유래 면역세포 유전자 재조합을 통한 암 면역질환 치료기술에 대한 공동연구를 추진하는 계약을...